Detail Information of Transcriptional Regulations
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0198 Transporter Info | ||||
Gene Name | SLC25A36 | ||||
Transporter Name | Solute carrier family 25 member 36 | ||||
Gene ID | |||||
UniProt ID | |||||
Transcriptional Regulation of This DT (TSR) | ||||||
---|---|---|---|---|---|---|
Class1.1: Basic leucine zipper factors |
Click to Show/Hide the Full List of 4 TF(s) Regulating This DT |
|||||
ATF3 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC25A36 gene | [1] | ||||
TF Protein Name |
Cyclic AMP-dependent transcription factor ATF-3 | Transcription Factor Info | ||||
Tissue |
Bone marrow; Colon; Embryo | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Cyclic AMP-dependent transcription factor ATF-3 (ATF3) can directly bind to the SLC25A36 gene, which in turn affects the expression or function of the drug transporter Solute carrier family 25 member 36. | |||||
CREB1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC25A36 gene | [2] | ||||
TF Protein Name |
Cyclic AMP-responsive element-binding protein 1 | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow; Colon; Embryo; Liver; Lung; Uterus | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Cyclic AMP-responsive element-binding protein 1 (CREB1) can directly bind to the SLC25A36 gene, which in turn affects the expression or function of the drug transporter Solute carrier family 25 member 36. | |||||
JUN |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC25A36 gene in coronary artery disease condition | [3] | ||||
TF Protein Name |
Transcription factor Jun | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Transcription factor Jun (JUN) has been reported to bind to the transcription of SLC25A36 gene in coronary artery disease condition, which leads to an affected expression of the drug transporter Solute carrier family 25 member 36. | |||||
JUND |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC25A36 gene | [1] | ||||
TF Protein Name |
Transcription factor JunD | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow; Brain; Colon; Embryo; Liver | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor JunD (JUND) can directly bind to the SLC25A36 gene, which in turn affects the expression or function of the drug transporter Solute carrier family 25 member 36. | |||||
Class1.2: Basic helix-loop-helix factors |
Click to Show/Hide the Full List of 7 TF(s) Regulating This DT |
|||||
AHR |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC25A36 gene | [4] | ||||
TF Protein Name |
Aryl hydrocarbon receptor | Transcription Factor Info | ||||
Tissue |
Breast | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Aryl hydrocarbon receptor (AHR) can directly bind to the SLC25A36 gene, which in turn affects the expression or function of the drug transporter Solute carrier family 25 member 36. | |||||
ARNT |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC25A36 gene | [5] | ||||
TF Protein Name |
Aryl hydrocarbon receptor nuclear translocator | Transcription Factor Info | ||||
Tissue |
Kidney | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Aryl hydrocarbon receptor nuclear translocator (ARNT) can directly bind to the SLC25A36 gene, which in turn affects the expression or function of the drug transporter Solute carrier family 25 member 36. | |||||
CLOCK |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC25A36 gene | [4] | ||||
TF Protein Name |
Circadian locomoter output cycles protein kaput | Transcription Factor Info | ||||
Tissue |
Brain; Colon | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Circadian locomoter output cycles protein kaput (CLOCK) can directly bind to the SLC25A36 gene, which in turn affects the expression or function of the drug transporter Solute carrier family 25 member 36. | |||||
HES1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC25A36 gene | [5] | ||||
TF Protein Name |
Transcription factor HES-1 | Transcription Factor Info | ||||
Tissue |
Colon; Liver | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor HES-1 (HES1) can directly bind to the SLC25A36 gene, which in turn affects the expression or function of the drug transporter Solute carrier family 25 member 36. | |||||
MAX |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC25A36 gene | [2] | ||||
TF Protein Name |
Protein max | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow; Breast; Liver; Lung; Uterus; Vein | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Protein max (MAX) can directly bind to the SLC25A36 gene, which in turn affects the expression or function of the drug transporter Solute carrier family 25 member 36. | |||||
MITF |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC25A36 gene in melanoma condition | [6] | ||||
TF Protein Name |
Microphthalmia-associated transcription factor | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Microphthalmia-associated transcription factor (MITF) has been reported to activate the transcription of SLC25A36 gene in melanoma condition, which leads to an increased expression of the drug transporter Solute carrier family 25 member 36. | |||||
MYC |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Repression of SLC25A36 gene in Burkitt lymphoma condition | [7] | ||||
TF Protein Name |
Myc proto-oncogene protein | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Down regulating | |||||
Detailed Description |
Myc proto-oncogene protein (MYC) has been reported to repress the transcription of SLC25A36 gene in Burkitt lymphoma condition, which leads to a decreased expression of the drug transporter Solute carrier family 25 member 36. | |||||
Class2.1: Nuclear receptors with C4 zinc fingers |
Click to Show/Hide the Full List of 4 TF(s) Regulating This DT |
|||||
AR |
Click to Show/Hide to Show 3 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC25A36 gene in prostate cancer condition | [8] | ||||
TF Protein Name |
Androgen receptor | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Androgen receptor (AR) has been reported to bind to the transcription of SLC25A36 gene in prostate cancer condition, which leads to an affected expression of the drug transporter Solute carrier family 25 member 36. | |||||
Transcriptional Phenomenon2 |
Binding to SLC25A36 gene in . condition | [9] | ||||
TF Protein Name |
Androgen receptor | Transcription Factor Info | ||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Androgen receptor (AR) has been reported to bind to the transcription of SLC25A36 gene in . condition, which leads to a affected expression of the drug transporter Solute carrier family 25 member 36. | |||||
Transcriptional Phenomenon3 |
Direct binding to SLC25A36 gene | [2] | ||||
TF Protein Name |
Androgen receptor | Transcription Factor Info | ||||
Tissue |
Breast; Cervix; Kidney; Prostate | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Androgen receptor (AR) can directly bind to the SLC25A36 gene, which in turn affects the expression or function of the drug transporter Solute carrier family 25 member 36. | |||||
ESR1 |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC25A36 gene in breast cancer condition | [10] | ||||
TF Protein Name |
Estrogen receptor | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Estrogen receptor (ESR1) has been reported to activate the transcription of SLC25A36 gene in breast cancer condition, which leads to an increased expression of the drug transporter Solute carrier family 25 member 36. | |||||
Transcriptional Phenomenon2 |
Direct binding to SLC25A36 gene | [1] | ||||
TF Protein Name |
Estrogen receptor | Transcription Factor Info | ||||
Tissue |
Breast | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Estrogen receptor (ESR1) can directly bind to the SLC25A36 gene, which in turn affects the expression or function of the drug transporter Solute carrier family 25 member 36. | |||||
PPARD |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Repression of SLC25A36 gene in myofibroblast condition | [11] | ||||
TF Protein Name |
Peroxisome proliferator-activated receptor delta | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Down regulating | |||||
Detailed Description |
Peroxisome proliferator-activated receptor delta (PPARD) has been reported to repress the transcription of SLC25A36 gene in myofibroblast condition, which leads to a decreased expression of the drug transporter Solute carrier family 25 member 36. | |||||
VDR |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC25A36 gene in leukemia condition | [12] | ||||
TF Protein Name |
Vitamin D3 receptor | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Vitamin D3 receptor (VDR) has been reported to bind to the SLC25A36 gene in leukemia condition, which leads to an affected expression of the drug transporter Solute carrier family 25 member 36. | |||||
Transcriptional Phenomenon2 |
Binding to SLC25A36 gene in THP-1 human monocytic leukemia cells condition | [13] | ||||
TF Protein Name |
Vitamin D3 receptor | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Vitamin D3 receptor (VDR) has been reported to bind to the transcription of SLC25A36 gene in THP-1 human monocytic leukemia cells condition, which leads to an affected expression of the drug transporter Solute carrier family 25 member 36. | |||||
Class2.2: Other C4 zinc finger-type factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
GATA4 |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC25A36 gene in gastric cancer condition | [14] | ||||
TF Protein Name |
Transcription factor GATA-4 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Transcription factor GATA-4 (GATA4) has been reported to activate the transcription of SLC25A36 gene in gastric cancer condition, which leads to an increased expression of the drug transporter Solute carrier family 25 member 36. | |||||
Transcriptional Phenomenon2 |
Direct binding to SLC25A36 gene | [2] | ||||
TF Protein Name |
Transcription factor GATA-4 | Transcription Factor Info | ||||
Tissue |
Heart | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor GATA-4 (GATA4) can directly bind to the SLC25A36 gene, which in turn affects the expression or function of the drug transporter Solute carrier family 25 member 36. | |||||
Class2.3: C2H2 zinc finger factors |
Click to Show/Hide the Full List of 5 TF(s) Regulating This DT |
|||||
KLF1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC25A36 gene | [4] | ||||
TF Protein Name |
Krueppel-like factor 1 | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Krueppel-like factor 1 (KLF1) can directly bind to the SLC25A36 gene, which in turn affects the expression or function of the drug transporter Solute carrier family 25 member 36. | |||||
KLF4 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC25A36 gene | [5] | ||||
TF Protein Name |
Krueppel-like factor 4 | Transcription Factor Info | ||||
Tissue |
Breast; Foreskin; Pancreatic ductal; Skin | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Krueppel-like factor 4 (KLF4) can directly bind to the SLC25A36 gene, which in turn affects the expression or function of the drug transporter Solute carrier family 25 member 36. | |||||
KLF5 |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC25A36 gene in gastric cancer condition | [14] | ||||
TF Protein Name |
Krueppel-like factor 5 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Krueppel-like factor 5 (KLF5) has been reported to activate the transcription of SLC25A36 gene in gastric cancer condition, which leads to an increased expression of the drug transporter Solute carrier family 25 member 36. | |||||
Transcriptional Phenomenon2 |
Direct binding to SLC25A36 gene | [4] | ||||
TF Protein Name |
Krueppel-like factor 5 | Transcription Factor Info | ||||
Tissue |
Colon; Pancreatic ductal; Stomach | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Krueppel-like factor 5 (KLF5) can directly bind to the SLC25A36 gene, which in turn affects the expression or function of the drug transporter Solute carrier family 25 member 36. | |||||
MAZ |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC25A36 gene | [1] | ||||
TF Protein Name |
Myc-associated zinc finger protein | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow; Cervix; Liver; Lung | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Myc-associated zinc finger protein (MAZ) can directly bind to the SLC25A36 gene, which in turn affects the expression or function of the drug transporter Solute carrier family 25 member 36. | |||||
ZNF217 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC25A36 gene in breast cancer condition | [15] | ||||
TF Protein Name |
Zinc finger protein 217 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Zinc finger protein 217 (ZNF217) has been reported to bind to the transcription of SLC25A36 gene in breast cancer condition, which leads to an affected expression of the drug transporter Solute carrier family 25 member 36. | |||||
Class3.1: Homeo domain factors |
Click to Show/Hide the Full List of 3 TF(s) Regulating This DT |
|||||
CDX2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC25A36 gene in health condition | [16] | ||||
TF Protein Name |
Homeobox protein CDX-2 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Homeobox protein CDX-2 (CDX2) has been reported to bind to the transcription of SLC25A36 gene in health condition, which leads to a affected expression of the drug transporter Solute carrier family 25 member 36. | |||||
CUX1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC25A36 gene in multiple human cancer types condition | [17] | ||||
TF Protein Name |
Homeobox protein cut-like 1 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Homeobox protein cut-like 1 (CUX1) has been reported to activate the transcription of SLC25A36 gene in multiple human cancer types condition, which leads to an increased expression of the drug transporter Solute carrier family 25 member 36. | |||||
NANOG |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC25A36 gene in HESC condition | [18] | ||||
TF Protein Name |
Homeobox protein NANOG | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Homeobox protein NANOG (NANOG) has been reported to activate the transcription of SLC25A36 gene in HESC condition, which leads to an increased expression of the drug transporter Solute carrier family 25 member 36. | |||||
Class3.3: Fork head / winged helix factors |
Click to Show/Hide the Full List of 6 TF(s) Regulating This DT |
|||||
E2F1 |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC25A36 gene in MCF7 cell lines | [19] | ||||
TF Protein Name |
Transcription factor E2F1 | Transcription Factor Info | ||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Transcription factor E2F1 (E2F1) has been reported to bind to the transcription of SLC25A36 gene in MCF7 cell lines, which leads to an affected expression of the drug transporter Solute carrier family 25 member 36. | |||||
Transcriptional Phenomenon2 |
Direct binding to SLC25A36 gene | [4] | ||||
TF Protein Name |
Transcription factor E2F1 | Transcription Factor Info | ||||
Tissue |
Mesenchymal | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor E2F1 (E2F1) can directly bind to the SLC25A36 gene, which in turn affects the expression or function of the drug transporter Solute carrier family 25 member 36. | |||||
E2F8 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC25A36 gene | [1] | ||||
TF Protein Name |
Transcription factor E2F8 | Transcription Factor Info | ||||
Tissue |
Cervix; Colon | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor E2F8 (E2F8) can directly bind to the SLC25A36 gene, which in turn affects the expression or function of the drug transporter Solute carrier family 25 member 36. | |||||
FOXA1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC25A36 gene | [1] | ||||
TF Protein Name |
Hepatocyte nuclear factor 3-alpha | Transcription Factor Info | ||||
Tissue |
Breast; Embryo; Liver; Lung; Pancreatic ductal; Prostate | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Hepatocyte nuclear factor 3-alpha (FOXA1) can directly bind to the SLC25A36 gene, which in turn affects the expression or function of the drug transporter Solute carrier family 25 member 36. | |||||
FOXA2 |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC25A36 gene in health condition | [20] | ||||
TF Protein Name |
Hepatocyte nuclear factor 3-beta | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Hepatocyte nuclear factor 3-beta (FOXA2) has been reported to bind to the transcription of SLC25A36 gene in health condition, which leads to an affected expression of the drug transporter Solute carrier family 25 member 36. | |||||
Transcriptional Phenomenon2 |
Direct binding to SLC25A36 gene | [2] | ||||
TF Protein Name |
Hepatocyte nuclear factor 3-beta | Transcription Factor Info | ||||
Tissue |
Colon | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Hepatocyte nuclear factor 3-beta (FOXA2) can directly bind to the SLC25A36 gene, which in turn affects the expression or function of the drug transporter Solute carrier family 25 member 36. | |||||
FOXM1 |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC25A36 gene in breast cancer condition | [21] | ||||
TF Protein Name |
Forkhead box protein M1 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Forkhead box protein M1 (FOXM1) has been reported to activate the transcription of SLC25A36 gene in breast cancer condition, which leads to an increased expression of the drug transporter Solute carrier family 25 member 36. | |||||
Transcriptional Phenomenon2 |
Direct binding to SLC25A36 gene | [2] | ||||
TF Protein Name |
Forkhead box protein M1 | Transcription Factor Info | ||||
Tissue |
Breast | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Forkhead box protein M1 (FOXM1) can directly bind to the SLC25A36 gene, which in turn affects the expression or function of the drug transporter Solute carrier family 25 member 36. | |||||
FOXP1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Repression of SLC25A36 gene in embryonic stem cell condition | [22] | ||||
TF Protein Name |
Forkhead box protein P1 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Down regulating | |||||
Detailed Description |
Forkhead box protein P1 (FOXP1) has been reported to repress the transcription of SLC25A36 gene in embryonic stem cell condition, which leads to a decreased expression of the drug transporter Solute carrier family 25 member 36. | |||||
Class3.5: Tryptophan cluster factors |
Click to Show/Hide the Full List of 4 TF(s) Regulating This DT |
|||||
ELK1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC25A36 gene | [23] | ||||
TF Protein Name |
ETS domain-containing protein Elk-1 | Transcription Factor Info | ||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
ETS domain-containing protein Elk-1 (ELK1) can directly bind to the SLC25A36 gene, which in turn affects the expression or function of the drug transporter Solute carrier family 25 member 36. | |||||
ETS1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC25A36 gene | [5] | ||||
TF Protein Name |
Protein C-ets-1 | Transcription Factor Info | ||||
Tissue |
Blood; Bone; Bone marrow; Kidney; Prostate; Vein | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Protein C-ets-1 (ETS1) can directly bind to the SLC25A36 gene, which in turn affects the expression or function of the drug transporter Solute carrier family 25 member 36. | |||||
GABPA |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC25A36 gene | [4] | ||||
TF Protein Name |
GA-binding protein alpha chain | Transcription Factor Info | ||||
Tissue |
Blood; Breast; Liver; Mesenchymal; Prostate | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
GA-binding protein alpha chain (GABPA) can directly bind to the SLC25A36 gene, which in turn affects the expression or function of the drug transporter Solute carrier family 25 member 36. | |||||
IRF1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC25A36 gene | [4] | ||||
TF Protein Name |
Interferon regulatory factor 1 | Transcription Factor Info | ||||
Tissue |
Bone marrow; Pancreatic ductal | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Interferon regulatory factor 1 (IRF1) can directly bind to the SLC25A36 gene, which in turn affects the expression or function of the drug transporter Solute carrier family 25 member 36. | |||||
Class3.7: ARID domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
ARID3A |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC25A36 gene | [5] | ||||
TF Protein Name |
AT-rich interactive domain-containing protein 3A | Transcription Factor Info | ||||
Tissue |
Liver | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
AT-rich interactive domain-containing protein 3A (ARID3A) can directly bind to the SLC25A36 gene, which in turn affects the expression or function of the drug transporter Solute carrier family 25 member 36. | |||||
Class6.4: Runt domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
RUNX2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC25A36 gene in prostate cancer condition | [24] | ||||
TF Protein Name |
Runt-related transcription factor 2 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Runt-related transcription factor 2 (RUNX2) has been reported to activate the transcription of SLC25A36 gene in prostate cancer condition, which leads to an increased expression of the drug transporter Solute carrier family 25 member 36. | |||||
TF Superclass7: beta-Hairpin exposed by an alpha/beta-scaffold |
||||||
Class7.1: SMAD/NF-1 DNA-binding domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
SMAD4 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC25A36 gene in epithelial ovarian cancer condition | [25] | ||||
TF Protein Name |
Mothers against decapentaplegic homolog 4 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Mothers against decapentaplegic homolog 4 (SMAD4) has been reported to bind to the transcription of SLC25A36 gene in epithelial ovarian cancer condition, which leads to an affected expression of the drug transporter Solute carrier family 25 member 36. | |||||
Class10.1: Other factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
GTF2B |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC25A36 gene | [5] | ||||
TF Protein Name |
Transcription initiation factor IIB | Transcription Factor Info | ||||
Tissue |
Cervix; Lung | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription initiation factor IIB (GTF2B) can directly bind to the SLC25A36 gene, which in turn affects the expression or function of the drug transporter Solute carrier family 25 member 36. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.